Table 1.
Association between miR-29a expression and clinicopathological characteristics of patients with NSCLC
| Variables | Patients (n) | Low miR-29a (n=41) | High miR-29a (n=37) | P-value |
|---|---|---|---|---|
| Age (years) | 0.927 | |||
| <55 | 27 | 14 | 13 | |
| ≥55 | 51 | 27 | 24 | |
| Gender | 0.262 | |||
| Male | 52 | 25 | 27 | |
| Female | 26 | 16 | 10 | |
| Tumor size | 0.723 | |||
| ≤4 cm | 49 | 25 | 24 | |
| >4 cm | 29 | 16 | 13 | |
| Differentiation | 0.011 | |||
| Well–moderate | 57 | 25 | 32 | |
| Poor | 21 | 16 | 5 | |
| Lymph node metastasis | 0.015 | |||
| No | 48 | 20 | 28 | |
| Yes | 30 | 21 | 9 | |
| Distant metastasis | 0.146 | |||
| No | 62 | 30 | 32 | |
| Yes | 16 | 11 | 5 | |
| Clinical stage | 0.003 | |||
| I–II | 39 | 14 | 25 | |
| III–IV | 39 | 27 | 12 |
Abbreviations: miR, microRNA; NSCLC, non-small cell lung cancer.